Opportunity Information: Apply for W81XWH 12 TSCRP IDA
Apply for W81XWH 12 TSCRP IDA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD FY12 Tuberous Sclerosis Complex Idea Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Mar 27, 2012 and posted on Mar 22, 2012.
- Applicants must submit their applications by May 31, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,280,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DOD FY12 Tuberous Sclerosis Complex (TSC) Idea Development Award (Funding Opportunity Number W81XWH-12-TSCRP-IDA) was a U.S. Department of Defense research funding opportunity administered through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), under CFDA 12.420 (Military Medical Research and Development). Its purpose was to support high-impact, innovative research projects that could meaningfully advance the TSC research field, with an emphasis on pushing new ideas forward rather than incremental work.
This award mechanism was intended for science and technology and broader research and development efforts, and it allowed funding through either a grant or a cooperative agreement. The program specifically encouraged preclinical research, signaling an interest in mechanistic studies, proof-of-concept work, model system research, and other non-human or translational efforts that could lay the groundwork for future therapeutic or diagnostic advances. At the same time, the announcement explicitly prohibited clinical trials, meaning applicants could not propose interventional human studies that fit typical clinical trial definitions.
A key application requirement was the inclusion of preliminary data directly relevant to tuberous sclerosis complex and to the proposed research project. In practice, this meant applicants needed to demonstrate some existing evidence supporting feasibility or rationale, such as prior results in cell culture, animal models, patient-derived samples, or other TSC-relevant datasets, rather than submitting purely speculative concepts without supporting data.
The opportunity was broadly open in terms of who could apply. Eligible applicants were listed as unrestricted, meaning it was open to any type of entity, subject to any additional eligibility clarifications that might have appeared in the full announcement. No cost sharing or matching funds were required, which reduced barriers for applicants who might not have institutional or third-party resources to contribute.
From a funding and timing standpoint, the program anticipated making about three awards, with an estimated total funding amount of $2,280,000. The opportunity was posted on March 22, 2012 (created March 27, 2012), and the application deadline was May 31, 2012, with the archive date listed as June 30, 2012. For technical issues accessing the full announcement, applicants were directed to the CDMRP Help Desk (PA HELP and eReceipt HELP) at 301-682-5507 or help@cdmrp.org.
FAQs: DOD FY12 Tuberous Sclerosis Complex (TSC) Idea Development Award (W81XWH-12-TSCRP-IDA)
What is this funding opportunity?
The DOD FY12 Tuberous Sclerosis Complex (TSC) Idea Development Award (Funding Opportunity Number W81XWH-12-TSCRP-IDA) was a U.S. Department of Defense research funding opportunity to support high-impact, innovative projects intended to meaningfully advance the tuberous sclerosis complex research field.
Which agency administered the program?
The opportunity was administered through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA).
What CFDA number is associated with this opportunity?
The opportunity was listed under CFDA 12.420 (Military Medical Research and Development).
What was the main purpose of the Idea Development Award?
The purpose was to support high-impact, innovative research projects, with an emphasis on pushing new ideas forward rather than funding incremental work.
What kind of research did the program aim to fund?
The mechanism was intended for science and technology and broader research and development efforts. The announcement specifically encouraged preclinical research, including mechanistic studies, proof-of-concept work, and model system research, as well as other non-human or translational efforts that could lay groundwork for future therapeutic or diagnostic advances.
Were clinical trials allowed under this opportunity?
No. The announcement explicitly prohibited clinical trials, meaning applicants could not propose interventional human studies that fit typical clinical trial definitions.
Was preliminary data required?
Yes. A key application requirement was the inclusion of preliminary data directly relevant to tuberous sclerosis complex and to the proposed project.
What did "preliminary data directly relevant to TSC" mean in practice?
Applicants needed to show existing evidence supporting feasibility or rationale (for example, prior results in cell culture, animal models, patient-derived samples, or other TSC-relevant datasets), rather than submitting purely speculative concepts without supporting data.
What funding instruments were available?
Funding could be provided through either a grant or a cooperative agreement.
Who was eligible to apply?
Eligible applicants were listed as unrestricted, meaning the opportunity was broadly open to any type of entity, subject to any additional eligibility clarifications that might have been included in the full announcement.
Was cost sharing or matching required?
No. The opportunity stated that no cost sharing or matching funds were required.
How many awards were expected to be made?
The program anticipated making about three awards.
What was the estimated total amount of funding available?
The estimated total funding amount was $2,280,000.
When was the opportunity posted?
The opportunity was posted on March 22, 2012 (created March 27, 2012).
What was the application deadline?
The application deadline was May 31, 2012.
When was the archive date for the opportunity?
The archive date was listed as June 30, 2012.
Where could applicants get help with technical issues accessing the full announcement?
Applicants were directed to the CDMRP Help Desk (PA HELP and eReceipt HELP) at 301-682-5507 or help@cdmrp.org for technical issues accessing the full announcement.
What was the program emphasis: incremental advances or new directions?
The emphasis was on innovative, high-impact work and pushing new ideas forward, rather than incremental research.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DOD FY12 Tuberous Sclerosis Complex Clinical Trial Award
Previous opportunity: DOD FY12 Tuberous Sclerosis Complex Exploration Hypothesis Development Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 12 TSCRP IDA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 12 TSCRP IDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DOD FY12 Tuberous Sclerosis Complex Clinical Trial Award Apply for W81XWH 12 TSCRP CTA Funding Number: W81XWH 12 TSCRP CTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Biophotonics Apply for PD 13 7236 Funding Number: PD 13 7236 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Biomedical Engineering Apply for PD 13 5345 Funding Number: PD 13 5345 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Biotechnology, Biochemical, and Biomass Engineering Apply for PD 13 1491 Funding Number: PD 13 1491 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Process and Reaction Engineering Apply for PD 13 1403 Funding Number: PD 13 1403 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Biosensing Apply for PD 13 7909 Funding Number: PD 13 7909 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Catalysis and Biocatalysis Apply for PD 13 1401 Funding Number: PD 13 1401 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Chemical and Biological Separations Apply for PD 13 1417 Funding Number: PD 13 1417 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Interfacial Processes and Thermodynamics Apply for PD 13 1414 Funding Number: PD 13 1414 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Research Interests of the Air Force Office of Scientific Research Apply for BAA AFOSR 2012 0001 Funding Number: BAA AFOSR 2012 0001 Agency: Air Force Office of Scientific Research Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Theoretical Research in Magnetic Fusion Energy Science Apply for DE FOA 0000707 Funding Number: DE FOA 0000707 Agency: Office of Science Category: Science and Technology and other Research and Development Funding Amount: $2,500,000 |
| Innovative Systems for Military Missions Apply for DARPA BAA 12 25 Funding Number: DARPA BAA 12 25 Agency: DARPA Tactical Technology Office Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Rocky Mountain CESU Apply for 07HQPA0028 Funding Number: 07HQPA0028 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: $24,957 |
| ROA 2007 A.6 Entry, Descent, and Landing 1 Apply for NNH07ZEA001N EDL1 Funding Number: NNH07ZEA001N EDL1 Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2012 Planetary Atmospheres Apply for NNH12ZDA001N PATM Funding Number: NNH12ZDA001N PATM Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2012 Laboratory Analysis of Returned Samples Apply for NNH12ZDA001N LARS Funding Number: NNH12ZDA001N LARS Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2012 Surface Water and Ocean Topography Mission Science Definition Team Apply for NNH12ZDA001N SWOT Funding Number: NNH12ZDA001N SWOT Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Peer Reviewed Medical Clinical Trial Award Apply for W81XWH 12 PRMRP CTA Funding Number: W81XWH 12 PRMRP CTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Peer Reviewed Medical Technology/Therapeutic Development Award Apply for W81XWH 12 PRMRP TTDA Funding Number: W81XWH 12 PRMRP TTDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Peer Reviewed Medical Discovery Award Apply for W81XWH 12 PRMRP DA Funding Number: W81XWH 12 PRMRP DA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 12 TSCRP IDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.